Cargando…
Clinical applications of retinal gene therapies
Retinal degenerative diseases are a major cause of blindness. Retinal gene therapy is a trail-blazer in the human gene therapy field, leading to the first FDA approved gene therapy product for a human genetic disease. The application of Clustered Regularly Interspaced Short Palindromic Repeat/Cas9 (...
Autores principales: | Fu, Xin, Huu, Viet Anh Nguyen, Duan, Yaou, Kermany, Daniel S, Valentim, Carolina C S, Zhang, Runze, Zhu, Jie, Zhang, Charlotte L, Sun, Xiaodong, Zhang, Kang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982485/ https://www.ncbi.nlm.nih.gov/pubmed/35694125 http://dx.doi.org/10.1093/pcmedi/pby004 |
Ejemplares similares
-
Gene and mutation independent therapy via CRISPR-Cas9 mediated cellular reprogramming in rod photoreceptors
por: Zhu, Jie, et al.
Publicado: (2017) -
CRISPR/Cas9 mediated somatic gene therapy for insertional mutations: the vibrator mouse model
por: Fu, Xin, et al.
Publicado: (2021) -
Early removal of senescent cells protects retinal ganglion cells loss in experimental ocular hypertension
por: Rocha, Lorena Raquel, et al.
Publicado: (2019) -
An effective and comprehensible method to detect and evaluate retinal damage due to diabetes complications
por: Dao, Quang Toan, et al.
Publicado: (2023) -
Simultaneous mechanical thrombectomy for bilateral acute internal carotid artery occlusion
por: Mai, Duy Ton, et al.
Publicado: (2021)